🔗 Visit the ClinicalTrials.gov page for NCT02008929
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy. | Acta Pharmacol Sin | 2015 | 0.92 |
| 2 | Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. | World J Hepatol | 2015 | 0.88 |
| 3 | Present and Future of Allogeneic Natural Killer Cell Therapy. | Front Immunol | 2015 | 0.86 |
| 4 | Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma. | J Clin Cell Immunol | 2015 | 0.84 |
| 5 | Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation. | Nanomedicine (Lond) | 2015 | 0.77 |
| 6 | Immunobiology of hepatocarcinogenesis: Ways to go or almost there? | World J Gastrointest Pathophysiol | 2016 | 0.76 |